Michael J Fox Foundation commits US$12m in 2011
To fund research into treatments and a cure for Parkinson\'s
The Michael J Fox Foundation has pledged up to US$12m in 2011 funding for research into treatments and a cure for Parkinson's disease.
Funding is open to academic and industry researchers through the Foundation's Pipeline Programmes, which consist of three annually recurring initiatives, known collectively as The Edmond J Safra Core Programmes for PD Research, as well as the industry exclusive Therapeutics Development Initiative.
The Foundation is looking for research proposals focused on:
• testing novel hypotheses;
• validating novel targets;
• catalysing and expanding preclinical development; and
• clinically testing novel therapies.
‘The Pipeline Programmes are a core element of our Foundation's efforts to drive research that will speed therapeutic development at historically under-funded points on the pipeline,’ said Todd Sherer, the Foundation's acting chief executive.
‘The programmes are part of MJFF's progressive work to keep the most promising and significant projects moving forward toward notably improving quality of life for patients now and in the future.’
The Michael J Fox Foundation, set up in 2000, has funded almost US$196m in research to date.